Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders

May 9, 2018 updated by: Harrison Walker, MD, University of Alabama at Birmingham

Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing Deep Brain Stimulation for Movement Disorders

The purpose of the study is to determine if non-invasive measurements of brain waves from the skin called electroencephalography (EEG) can predict whether the brain stimulator will help your symptoms. Our goal is to obtain these brain wave measurements with patients both awake and under general anesthesia, and then to evaluate which brain wave patterns are associated with clinical improvement to determine if they could be useful for predicting whether the surgery will work. If such predictive measures were established based upon the findings of this study, they could be used in the future to improve surgical outcomes in the following ways: (1) to help guide surgical targeting in the operating room awake or under anesthesia, (2) to guide post-operative programming in clinic, and (3) and to develop potential feedback systems for "automatic" programming of the brain stimulator system at home.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

21

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients who undergo deep brain stimulation as part of routine clinical care for movement disorders (Parkinson's disease, essential tremor, dystonia, Tourette's syndrome).

Description

Inclusion Criteria:

  1. Patients who elect to undergo deep brain stimulation as part of routine clinical care for movement disorders (Parkinson's disease, essential tremor, dystonia, Tourette's syndrome).
  2. Adults, ages 19 and older

Exclusion Criteria:

  1. Patients who are outside the age range for inclusion
  2. Patients who are unable to consent to the research for cognitive or behavioral reasons
  3. Patients who are medically too ill to participate, and
  4. Patients who have their DBS programming at outside facilities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
DBS subjects
deep brain stimulation (DBS) in patients with Parkinson's disease, tremor, dystonia, and Tourette's syndrome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Time Frame: Change in the rating scale score at 6 months post-op versus pre-op baseline
Validated rating scale for measuring symptoms of Parkinson's disease
Change in the rating scale score at 6 months post-op versus pre-op baseline
The Essential Tremor Rating Assessment Scale (TETRAS)
Time Frame: Change in the rating scale score at 6 months post-op versus pre-op baseline
Validated rating scale for measuring symptoms of essential tremor
Change in the rating scale score at 6 months post-op versus pre-op baseline
Burke-Fahn-Marsden (BFM) Dystonia Rating Scale
Time Frame: Change in the rating scale score at 6 months post-op versus pre-op baseline
Validated rating scale for measuring symptoms of primary dystonia
Change in the rating scale score at 6 months post-op versus pre-op baseline
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)
Time Frame: Change in the rating scale score at 6 months post-op versus pre-op baseline
Validated rating scale for measuring symptoms of primary cervical/segmental dystonia
Change in the rating scale score at 6 months post-op versus pre-op baseline
Yale Global Tic Severity Scale
Time Frame: Change in the rating scale score at 6 months post-op versus pre-op baseline
Validated rating scale for tic severity
Change in the rating scale score at 6 months post-op versus pre-op baseline
Deep Brain Stimulation (DBS) Therapeutic Window
Time Frame: 1 month post-operative scores for each contact on the DBS electrode array
Measurement of the available range of stimulation intensities for therapy for each contact on the DBS electrode array
1 month post-operative scores for each contact on the DBS electrode array

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Harrison Walker, MD, University of Alabama at Birmingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

June 29, 2015

First Submitted That Met QC Criteria

June 30, 2015

First Posted (Estimate)

July 2, 2015

Study Record Updates

Last Update Posted (Actual)

May 11, 2018

Last Update Submitted That Met QC Criteria

May 9, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • F140225003

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Movement Disorders

3
Subscribe